Pinnacle West Capital to Release Q2 Earnings: What to Expect? — Positive
PNW Zacks Investment Research — July 30, 2025PNW's Q2 performance is expected to have continued to benefit from retail electricity sales. Yet, higher depreciation and amortization might have offset some positives.
Regions Financial (RF) Just Flashed Golden Cross Signal: Do You Buy? — Positive
RF Zacks Investment Research — July 30, 2025Regions Financial Corporation (RF) reached a significant support level, and could be a good pick for investors from a technical perspective. Recently, RF's 50-day simple moving average broke out above its 200-day moving average; this is known as a "golden cross.
Can Rigel (RIGL) Climb 69.55% to Reach the Level Wall Street Analysts Expect? — Positive
RIGL Zacks Investment Research — July 30, 2025The average of price targets set by Wall Street analysts indicates a potential upside of 69.6% in Rigel (RIGL). While the effectiveness of this highly sought-after metric is questionable, the positive trend in earnings estimate revisions might translate into an upside in the stock.
Pan American Silver (PAAS) May Find a Bottom Soon, Here's Why You Should Buy the Stock Now — Positive
PAAS Zacks Investment Research — July 30, 2025Pan American Silver (PAAS) appears to have found support after losing some value lately, as indicated by the formation of a hammer chart. In addition to this technical chart pattern, strong agreement among Wall Street analysts in revising earnings estimates higher enhances the stock's potential for a turnaround in the near term.
Wall Street Analysts Think West Pharmaceutical (WST) Could Surge 25.26%: Read This Before Placing a Bet — Positive
WST Zacks Investment Research — July 30, 2025The consensus price target hints at a 25.3% upside potential for West Pharmaceutical (WST). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate revisions could mean that the stock will witness an upside in the near term.
Down 15.6% in 4 Weeks, Here's Why You Should You Buy the Dip in Brown & Brown (BRO) — Positive
BRO Zacks Investment Research — July 30, 2025Brown & Brown (BRO) has become technically an oversold stock now, which implies exhaustion of the heavy selling pressure on it. This, combined with strong agreement among Wall Street analysts in revising earnings estimates higher, indicates a potential trend reversal for the stock in the near term.
Here's Why Fresenius (FMS) Looks Ripe for Bottom Fishing — Neutral
FMS Zacks Investment Research — July 30, 2025Fresenius (FMS) witnesses a hammer chart pattern, indicating support found by the stock after losing some value lately. This coupled with an upward trend in earnings estimate revisions could mean a trend reversal for the stock in the near term.
Down 29.2% in 4 Weeks, Here's Why NeoGenomics (NEO) Looks Ripe for a Turnaround — Positive
NEO Zacks Investment Research — July 30, 2025NeoGenomics (NEO) is technically in oversold territory now, so the heavy selling pressure might have exhausted. This along with strong agreement among Wall Street analysts in raising earnings estimates could lead to a trend reversal for the stock.
Does Genius Sports Limited (GENI) Have the Potential to Rally 26.06% as Wall Street Analysts Expect? — Positive
GENI Zacks Investment Research — July 30, 2025The mean of analysts' price targets for Genius Sports Limited (GENI) points to a 26.1% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts in raising earnings estimates does indicate an upside in the stock.
Wall Street Analysts See a 30.18% Upside in Aris Mining Corporation (ARMN): Can the Stock Really Move This High? — Positive
ARMN Zacks Investment Research — July 30, 2025The average of price targets set by Wall Street analysts indicates a potential upside of 30.2% in Aris Mining Corporation (ARMN). While the effectiveness of this highly sought-after metric is questionable, the positive trend in earnings estimate revisions might translate into an upside in the stock.
TransAlta (TAC) Just Flashed Golden Cross Signal: Do You Buy? — Positive
TAC Zacks Investment Research — July 30, 2025From a technical perspective, TransAlta Corporation (TAC) is looking like an interesting pick, as it just reached a key level of support. TAC's 50-day simple moving average crossed above its 200-day simple moving average, which is known as a "golden cross" in the trading world.
Does Nomad Foods (NOMD) Have the Potential to Rally 37.22% as Wall Street Analysts Expect? — Positive
NOMD Zacks Investment Research — July 30, 2025The mean of analysts' price targets for Nomad Foods (NOMD) points to a 37.2% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts in raising earnings estimates does indicate an upside in the stock.
Wall Street Analysts Believe HNI (HNI) Could Rally 32.65%: Here's is How to Trade — Positive
HNI Zacks Investment Research — July 30, 2025The average of price targets set by Wall Street analysts indicates a potential upside of 32.7% in HNI (HNI). While the effectiveness of this highly sought-after metric is questionable, the positive trend in earnings estimate revisions might translate into an upside in the stock.
Prime Medicine, Inc. (PRME) Now Trades Above Golden Cross: Time to Buy? — Positive
PRME Zacks Investment Research — July 30, 2025After reaching an important support level, Prime Medicine, Inc. (PRME) could be a good stock pick from a technical perspective. PRME recently experienced a "golden cross" event, which saw its 50-day simple moving average breaking out above its 200-day simple moving average.
Wall Street Analysts Believe Montrose Environmental (MEG) Could Rally 31.31%: Here's is How to Trade — Positive
MEG Zacks Investment Research — July 30, 2025The consensus price target hints at a 31.3% upside potential for Montrose Environmental (MEG). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate revisions could mean that the stock will witness an upside in the near term.
Wall Street Analysts Believe Tango Therapeutics (TNGX) Could Rally 61.46%: Here's is How to Trade — Positive
TNGX Zacks Investment Research — July 30, 2025The mean of analysts' price targets for Tango Therapeutics (TNGX) points to a 61.5% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts in raising earnings estimates does indicate an upside in the stock.
Meta Platforms is scheduled to report earnings after Wednesday's close. The stock recently hit a record high near $747.90/share and is currently trading near $702.
Microsoft Earnings: AI Growth And Cloud Demand Are Front & Center — Positive
MSFT Forbes — July 30, 2025Microsoft Inc. is scheduled to report earnings after Wednesday's close. The stock just hit another fresh record high just above $518/share and is currently trading near that level.
Palo Alto Networks Stock Down 14% On Dubious $25 Billion CyberArk Buy — Negative
PANW Forbes — July 30, 2025Santa Clara, Calif.-based cybersecurity platform provider Palo Alto Networks stock has lost 14% of its peak value since inking a deal to acquire Newton, Mass.
Check Point Software Leads Email Security Rankings in 2025 GigaOm Radar Anti-Phishing Report — Neutral
CHKP GlobeNewsWire — July 30, 2025Check Point has been recognized as a Leader and Outperformer for its Harmony Email & Collaboration security solution in GigaOm's latest Radar Report.
